HYDRA-ZIDE
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Approval overview HYDRA-ZIDE is listed in Drugs@FDA under application 088961 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength CAPSULE;ORAL - 100MG;50MG Sponsor STRIDES PHARMA INTL Submission history Latest submission status date: 2020-08-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview HYDRA-ZIDE is listed in Drugs@FDA under application 088961 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength CAPSULE;ORAL - 100MG;50MG Sponsor STRIDES PHARMA INTL Submission history Latest submission status date: 2020-08-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.